CLEARD3
8.2.2024 10:31:36 CET | Business Wire | Press release
ClearD3™, an innovator in data- and AI-driven pricing, announces the successful implementation of its quote pricing technology at Van den Bosch, a prominent family-owned intermodal transport company.
The operational results for 2023 are in and Van den Bosch has seen a considerable improvement in contribution margin for business covered by ClearD3 - a result that has been objectively measured using A/B testing. ClearD3’s pricing technology is applicable to all types of industrial and freight transport applications.
Van den Bosch, with a rich legacy and a stronghold in bulk freight logistics, sought a solution to navigate the unprecedented volatility in capacity and prices post-Covid. Their existing, predominantly manual pricing model, coupled with limited information, prompted a critical evaluation of the efficacy of Machine Learning and external data integration.
ClearD3™ implemented an automated external supply-chain data-driven pricing system for Van den Bosch. The primary goal was to achieve maximum cash contribution margins by matching the company’s quotes with estimated demand for lanes, departing from the industry-standard "cost plus margin" approach.
"We are delighted with the outcomes of our collaboration with ClearD3," expressed Rico Daandels, CEO at Van den Bosch. "The contribution margin improvement underscores the effectiveness of ClearD3™ in optimizing our pricing strategy, enabling us to stay ahead in a rapidly evolving market. The needs of society, customers, employees and network are changing with sustainability playing an increasing role. Solutions change with it. For the long term, we want to further increase our positive impact to make the bulk sector more sustainable together. Data plays a big role in this."
ClearD3's solution not only enhances pricing performance but also aligns with Van den Bosch's commitment to leading the digital transition in transport. This collaboration signifies a major leap forward in leveraging technology to achieve operational excellence and competitive advantage.
About van den Bosch:
Van den Bosch Transporten is a leading international logistics service provider. With a strong specialization in bulk transport (both liquid and dry), the company offers a comprehensive range of transport solutions, using various modalities like road, rail, and water. Van den Bosch is known for its innovative approach to logistics, focusing on sustainability, efficiency, and leveraging advanced technology to meet the evolving needs of the transport industry.
About ClearD3™:
ClearD3™ is a leading provider of supply chain data and AI driven solutions, specializing in optimizing pricing strategies and supply-chain processes for businesses across various industries. With a focus on innovation and efficiency, ClearD3™ empowers organizations to make better informed decisions in dynamic market environments.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240208424329/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Demand for GP Financing Is Rising, but the Managers Who Need It Most Are Finding It Hardest to Access23.4.2026 10:00:00 CEST | Press release
Corpay Private Markets publishes its fourth Lender Book Report, drawing on proprietary transaction data and live lender appetite tracking across 500+ lenders Corpay Private Markets, formerly Alpha Private Markets, today publishes the fourth edition of its Lender Book Report, focusing on GP financing across private markets. While demand for GP-level liquidity is rising – driven by longer fundraising cycles, slower exit activity, and increasing GP commitment requirements – access to financing is not expanding evenly. That is the central finding of the latest Lender Book Report. Unlike most research in the fund finance sector, which draws on surveys and reflects market sentiment, the Lender Book Report series is built on proprietary data. This edition combines insights from Alpha Match, Corpay Private Markets' lending intelligence platform tracking 500+ active lenders, with anonymised data from recent GP financing transactions. The data reveals a structural gap. Although the number of GP
Pantheon Expands Global Private Wealth Platform with Infrastructure Secondaries Fund Launch23.4.2026 10:00:00 CEST | Press release
Now with new international vehicle, Pantheon offers clients global evergreen access to full suite of private equity, private credit secondaries, and infrastructure secondaries Pantheon bolsters its globally recognized, specialist approach in infrastructure secondaries in the evergreen market with the launch of the Pantheon Global Infrastructure Secondaries Fund (“PGIS”) PGIS will tap the expertise of Pantheon’s $26.9 billion1 institutional infrastructure franchise Fund marks latest in Pantheon’s growing, $15 billion2 global evergreen platform, which now includes semi-liquid evergreen offerings across private equity, private credit secondaries and infrastructure secondaries in the US and internationally3 Pantheon, a leading global private markets investor, today announced the regulatory approval for the Pantheon Global Infrastructure Secondaries Fund (“PGIS”). Domiciled in Luxembourg, the evergreen fund represents a significant milestone in Pantheon’s private wealth strategy and the exp
KAYTUS Unveils MotusAI Enhancements with OpenClaw for Enterprise-Grade AI Agents23.4.2026 09:02:00 CEST | Press release
Providing a high-availability compute foundation for seamless AI agent deployment, greater resource efficiency, and enterprise-grade reliability. KAYTUS, a leading provider in AI infrastructure and liquid cooling solutions, today launched new capabilities in its MotusAI AI DevOps platform to accelerate the deployment of enterprise-grade AI agents. By a streamlined three-step integration with the OpenClaw framework, MotusAI provides the compute infrastructure, resource orchestration, and operational support required to address deployment bottlenecks, and enable AI agents to scale from early-stage experimentation to dependable enterprise use. Key Challenge for Enterprise-Grade AI Agents: Guaranteed Reliability and Performance As the AI landscape transitions from chatbots to AI agents, enterprises are facing a fundamental constraint: the value of even the most advanced large language model (LLM) depends on the stability and performance of the underlying execution infrastructure. At presen
Samsung Epis Holdings Reports First Quarter 2026 Financial Results23.4.2026 08:54:00 CEST | Press release
Samsung Bioepis recorded Q1’26 revenue of KRW 454.9 billion and operating profit of KRW 144.0 billion Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced its financial results for the first quarter of fiscal year 2026. “Samsung Bioepis delivered solid growth this quarter driven by continued momentum across our biosimilar portfolio," said Kyung-Ah Kim, President and Chief Executive Officer (CEO) of Samsung Epis Holdings. “We are further strengthening our position through new global partnerships and continued portfolio expansion. As we mark the 10th anniversary of the launch of our first biosimilar in Europe, we remain focused on building on our legacy while investing strategically to support long-term growth. We remain committed to delivering sustainable value for our shareholders.” First Quarter 2026 Results On a standalone basis, in the first quarter of 2026, Samsung Bioepis posted a revenue of KR
Galderma Reports Strong Start to the Year, Delivering First Quarter 2026 Net Sales of 1.473 Billion USD, Growing 25.5% at Constant Currency23.4.2026 07:00:00 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026. Strong start to the year delivering net sales of 1,473 million USD, predominantly driven by volume and complemented by positive price and mix effects, underscoring the continued execution of its unique, growth-driven integrated dermatology strategy. Widespread net sales growth of 25.5% year-on-year at constant currency1,aligned with strong growth performance across geographies and product categories, including Injectable Aesthetics (+13.1%), Dermatological Skincare (+17.0%) and Therapeutic Dermatology (+71.3%). Continued market outperformance, with broad-based growth momentum across the existing portfolio, complemented by differentiated launches and geographic expansion. Demonstrated scientific leadership with new clinical data presented at major congresses, including positive phase II results for nemoli
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom